Application of the ANRORC-Process for the Directional Synthesis of 5-Ureido-2-Pyrazolines as a Biologically Active Co-Ligand of Gold Glyconanoparticles

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Interaction of 1-phenyl-4,6-dimethylpyrimidine-2(1H)-one with 4-mercaptobuturic acid hydrazide proceeds as ANRORC (Addition of the Nucleophile–Ring Opening–Ring Closure) process and gives in the formation with 60% yield of 1-(4-mercaptobutanoyl)-3,5-dimethyl-5-(3-phenylcarbamoylamino)-2-pyrazoline as promising сo-ligand for the preparation of gold glyconanoparticles for biomedical purposes.

Sobre autores

A. Ershov

Institute of Macromolecular Compounds of the Russian Academy of Sciences

Email: martynenkoff@gmail.com
ORCID ID: 0000-0002-2266-4380
Rússia, Bol′shoi prosp., 31, St. Petersburg, 199004

A. Martynenkov

Institute of Macromolecular Compounds of the Russian Academy of Sciences

Autor responsável pela correspondência
Email: martynenkoff@gmail.com
ORCID ID: 0000-0002-0951-1451
Rússia, Bol′shoi prosp., 31, St. Petersburg, 199004

I. Lagoda

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: martynenkoff@gmail.com
ORCID ID: 0000-0002-3906-2909
Rússia, Lesoparkovaya ul., 4, St. Petersburg, 195043

A. Batyrenko

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: martynenkoff@gmail.com
ORCID ID: 0000-0001-9688-3650
Rússia, Lesoparkovaya ul., 4, St. Petersburg, 195043

Bibliografia

  1. Glycochemical synthesis: strategies and applications. Ed. S.-C. Hung, M. M. L. Zulueta. Hoboken, New Jersey: John Wiley & Sons Inc. 2016. doi: 10.1002/978 1119006435.ch16
  2. Mu W., Chu Q., Liu Y., Zhang N. Nano-Micro Lett. 2020, 12, е142. doi: 10.1007/s40820-020-00482-6
  3. Boije af Gennäs G., Mologni L., Ahmed S., Rajaratnam M., Marin O., Lindholm N., Viltadi M., Gambacorti-Passerini C., Scapozza L., Yli-Kauha-luoma J. Chem. Med. Chem. 2011, 6, 1680–1692. doi: 10.1002/cmdc.2011 00168
  4. Matiadis D., Sagnou M. Int. J. Mol. Sci. 2020, 21, e5507. doi: 10.3390/ijms21155507
  5. Naim M.J., Alam O., Nawaz F., Alam J., Alam P. J. Pharm. Bioallied Sci. 2016, 8, 2–17. doi: 10.4103/0975-7406.171694
  6. Jazayeri M.H., Amani H., Pourfatollah A.A., Avan A., Ferns G.A., Pazoki-Toroudi H. Cancer Gene Ther. 2016, 23, 365–369. doi: 10.1038/cgt.2016.42
  7. Ershov A.Y., Koshmina N.V. Arkivoc, 2000, vi, 917–922. doi: 10.3998/ark.5550190.0001.609
  8. Ершов А.Ю., Гиндин В.А., Грибанов А.В. ЖОрХ. 1997, 33, 438–441. [Ershov A.Y., Gindin V.V., Gribanov A.V. Russ. J. Org. Chem. 1997, 33, 388–391]. https:// www.pleiades. online/abstract/orgchem/97/orgchem0388_abstract.pdf
  9. van der Plas H.C. Adv. Heterocycl. Chem., 1999, 74, 87–151. doi: 10.1016/S0065-2725(08)60810-7
  10. Цаплин Г.В., Попков С.В. ЖOрХ. 2022, 58, 6–22. [Tsaplin G.V., Popkov S.V. Russ. J. Org. Chem. 2022, 58, 1–14.] doi: 10.1134/S1070428022010018
  11. Kashima C., Katoh A., Yokota Y., Omote Y. Chem. Pharm. Bull. 1981, 29, 2516–2519.
  12. doi: 10.1248/cpb.29.2516
  13. von Delius M., Geertsema E.M., Leigh D.A. Nat. Chem. 2010, 2, 96–101. doi 10.1038/ nchem.481.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Russian Academy of Sciences, 2025